Minister to launch Limerick famine walkway

first_imgTwitter TAGSfamineJImmy DeenihanknockfiernaMusic Limerick Advertisement Email Celebrating a ground breaking year in music from Limerick #SaucySoul: Room 58 – ‘Hate To See You Leave’ WhatsApp RELATED ARTICLESMORE FROM AUTHOR #HearThis: New music and video from Limerick rapper Strange Boy Printcenter_img Previous articleCalling all Limerick Rugby Clubs #UBLNext articleMilford Care Centre to benefit from Limerick table quiz Editor Heritage Minister Jimmy Deenihan will visit the Knockfierna Heritage Park this Saturday, February 1 to launch a brochure guide and reopen the pre-famine walkways.The commonage landscape of over 150 acres remains intact since it was abandoned during the great famine of 1847, leaving only the ruins of cabins, the unfinished landscape and the pre-famine potatoe ridges.Sign up for the weekly Limerick Post newsletter Sign Up The pre-famine roads through the hill have been made accessible once again; work over of the years has seen around three miles of pathways being restored. There are also picturesque views of the surrounding six counties to be enjoyed when visiting the area.The Knockfierna Heritage Society still celebrates the festival of Lughnasa at the hillside, which has been celebrated on the site since ancient times. The festival is held the last Sunday of July each year.Saturdays ceremonies will get under way at 2:30pm. NewsMinister to launch Limerick famine walkwayBy Editor – January 27, 2014 3269 Watch the streamed gig for Fergal Nash album launch Emma Langford shortlisted for RTE Folk Award and playing a LIVE SHOW!!! this Saturday Linkedin Facebook WATCH: Knockfierna beat Gerald Griffins to Claim West Junior Titlelast_img read more

Read More →

Time called on JP’s big charity pro-am

first_imgNewsLocal NewsTime called on JP’s big charity pro-amBy Alan Jacques – January 24, 2014 894 TAGSGary LinekerHugh GrantJP McManusMichael DouglasMilford HospiceMusic LimerickPadraig HarringtonSamuel L JacksonTiger Woods Advertisement WhatsApp Facebook Email Previous articleCouncil tribute to ‘quiet man’ PeadarNext articleGenerous response to sick Limerick mother’s appeal Alan Jacqueshttp://www.limerickpost.ie Seven winners overall for JP as he takes Leading Owner award at Cheltenham JP McManus’ legendary Istabraq to be honoured on Laochra na Rásáiochta Limerick Post Show | April 10, 2020 center_img Twitter Light Up A Memory 2020 ceremony at Milford Hospice goes virtual Print 2021 JP McManus Pro-Am postponed for one year Limerick hurlers #HitTheWoahForMilfordHospice RELATED ARTICLESMORE FROM AUTHOR BILLIONAIRE JP McManus‘ Invitational Pro-Am, which has brought some of the world’s best golfers and famous stars to Limerick every five years and raised millions for charities, will not go ahead next year.The decision to call a halt to the country’s biggest charity fundraiser, which raised over €100 million since its inception in 1990, is understood to have been made in the last week after meetings between JP and the committee involved in running the event. It has been reported that Ireland’s tax residency laws were a major bone of contention for McManus as it limited the amount of time he could spend here to organise the Pro-Am.Sign up for the weekly Limerick Post newsletter Sign Up The star-studded spectacular, which was due to tee off in Limerick in 2015, is now unlikely to go ahead. Over the years the charity event has drawn household names from the worlds of sport and film including Tiger Woods, Michael Douglas, Samuel L Jackson, Padraig Harrington, Gary Lineker, Hugh Grant and Michael Owen to the Mid-West.The event, was a huge money spinner for the local economy, however, it is the many Limerick charities the Pro-Am raised millions in funding for over the years that will be hardest hit by this week’s news.Chief executive of Milford Care Centre, Pat Quinlan commented, “We owe JP and the Pro Am Committee an enormous debt of gratitude and fully appreciate the remarkable generosity of his significant support down through the years.” Linkedinlast_img read more

Read More →

Limerick runners attempt to break world record

first_imgNewsLocal NewsLimerick runners attempt to break world recordBy Alan Jacques – January 9, 2015 915 Facebook Linkedin Print Advertisement WATCH: “Everyone is fighting so hard to get on” – Pat Ryan on competitive camogie squads OVER 100 runners from all over Limerick will come together at the University of Limerick this Sunday, January 11 at 11am in an attempt to break the world record for a relay marathon and enter the Guinness World Record books.The current record stands at two hours and 10 minutes and 52 seconds, which means runners will have to average 74 seconds per lap to break the record.Sign up for the weekly Limerick Post newsletter Sign Up Each runner will complete a 400m lap of the running track in UL. The final 105th lap is a group event for anyone wishing to be involved in this challenge.This event is the brain child of Derek Casey from Limerick Brakes, who are kindly sponsoring this event.Derek commented, “ I am a member of a local running club in south Limerick called An Brú Ac and after competing in this year’s Dublin Marathon, I decided i wanted to give something back to a charity while also setting a challenge for myself.”“I am delighted to help a local charity, Cliona’s Foundation, who provide financial support to families with a seriously ill child. Cliona’s Foundation believes that no family should have to face any added financial stress when they are already struggling to cope with the devastation and trauma of a seriously ill child. We are delighted to be involved with the Cliona Foundation and with both Brendan and Terry Ring,” said Derek.All proceeds raised in advance and on the day will go to the Cliona Foundation.The goal on the day is to break the world record and to raise much needed funds for Cliona’s Foundation. Gary O’Hanlon, a well known athlete from Clonliffe Harriers, will kick off the relay marathon.Registration is €10, which is payable on the day or people can donate to www.mycharity.ie/event/clionas_foundation_relay_marathon.For further details, please contact Derek Casey on 086 0693600 or log onto the facebook page Cliona’s Foundation Marathon Relay. Email TAGSCliona’s FoundationGuinness World RecordlimerickUniversity of Limerick Previous articleThree stories told through modern danceNext articleEarls returns to Munster squad to face Zebre Alan Jacqueshttp://www.limerickpost.ie center_img Twitter Vanishing Ireland podcast documenting interviews with people over 70’s, looking for volunteers to share their stories RELATED ARTICLESMORE FROM AUTHOR Predictions on the future of learning discussed at Limerick Lifelong Learning Festival Limerick Artist ‘Willzee’ releases new Music Video – “A Dream of Peace” Limerick’s National Camogie League double header to be streamed live WhatsApp Limerick Ladies National Football League opener to be streamed livelast_img read more

Read More →

Fianna Fáil told to stop picking on pensioners and families in…

first_imgLimerick TD says GLAS payments welcome but ‘much more action’ needed to support Agri-sector RELATED ARTICLESMORE FROM AUTHOR Fianna Fáil TD Niall Collins appointed as Minister of State Councillors told to look at bigger picture Twitter TAGSCllr Frankie DalyCllr Kevin SheahanCllr Sean LynchFianna Fáilfree GP careIrish Medical OrganisationLabour Partylimerick Previous articleHotel Meyrick CompetitionNext articleRugby – Richmond RFC take part in Aviva Mini Rugby Festival Alan Jacqueshttp://www.limerickpost.ie Decision to enter Phase 4 of reopening Ireland deferred to August 10 WhatsApp Priority is to have a decent society with decent public services center_img by Alan [email protected] up for the weekly Limerick Post newsletter Sign Up Cllr Frankie DalyLABOUR Party councillor Frankie Daly has called on local Fianna Fáil councillors to publicly state whether they support free GP care or oppose it, in line with their party’s national position.Cllr Daly maintains that the agreement reached between the Government and the Irish Medical Organisation recently to provide free GP care to children under 6 and over 70s will make a massive difference to the youngest and oldest in our community.“It is the most significant development in primary care since the introduction of medical cards, and will deliver significant savings for families in Limerick City and Council,” the City North representative declared.“In a bizarre move, Fianna Fáil have decided to oppose the provision of the free service, with one of their TDs even describing the measure as ‘reprehensible, immoral and nauseating’,” he continued.In light of this, Cllr Daly is calling on local Fianna Fáil councillors to state publicly if they agree with their party’s national position on the new scheme, which he insists will benefit thousands of children in Limerick.“It is clear that Fianna Fáil are out of touch and don’t have any appreciation whatsoever for the severe pressure that families are under. It is high time that Fianna Fáil laid off targeting hard-pressed families and older people, and supported this progressive move,” he said.The Fianna Fáil Mayor of Limerick City and County, Cllr Kevin Sheahan, said he had no comment to make when asked whether he agreed with his party’s national position on the free GP scheme.Fianna Fáil councillor for City West, Sean Lynch praised Cllr Daly for his integrity and the passion he brings on all topics relevant to Limerick City and County. However, he believes the Labour representative may have misinterpreted Fianna Fáil policy on health care.“Fianna Fáil have always been the party of the people. They would expand on the free GP care for both the young and old,” Cllr Lynch commented.“They will focus on primary and community care services and increase primary care budget.” Facebook NewsLocal NewsFianna Fáil told to stop picking on pensioners and families in LimerickBy Alan Jacques – April 23, 2015 697 Linkedin Top Fianna Fáil councillor will reject Green coalition deal Email Advertisement Printlast_img read more

Read More →

Limerick businessman jailed for money laundering

first_imgThe Limerick man was jailed for money laundering and drugs offencesA LIMERICK man whose business folded during the economic crash has been jailed for two years for laundering €73,000 and storing €53,000 worth of drugs in what Gardaí described as a “highly sophisticated grow house”.At Limerick Circuit Court this week, Kenneth Moore (46) of Portcrusha, Montpellier pleaded guilty to possessing cannabis and money laundering contrary to Section 7 of the Criminal Justice Money Laundering and Terrorist Financing Act.Sign up for the weekly Limerick Post newsletter Sign Up On June 12, 2013, Gardaí searched a property in county Limerick where they found two shed-like containers. One had been converted into a sophisticated grow house and the other had compartments filled with cannabis behind a false wall.Drugs, cash and a counting machine were found at a stables nearby.Judge Tom O’Donnell was told that 14 cannabis plants found on the property were valued at €800 each while the harvested cannabis had a street value of €37,000. The cash, which was in two bundles, totalled €73,000.Describing Kenneth Moore as a “storehouse man for drugs and the cash”, Judge O’Donnell said that people who get involved in this type of offence must be prepared to accept the circumstances of their actions.As a result of his business failing, he had substantial debts and fell in to difficulty when he was unable to repay money he borrowed from “an unsavoury source”.He said that the sentencing regime provided for a presumptive mandatory minimum prison sentence of ten years, but the court could deviate from that if the circumstances made it unjust to impose such a sentence.There was a substantial amount of drugs and cash involved but Mr Moore had cooperated and was said to have been “at the lower end of the pyramid”. He also had a substantial debt burden and was under duress.After imposing a two year prison term on the drugs and money laundering charges, Judge O’Donnell suspended a second two year sentence for a period of six years. Predictions on the future of learning discussed at Limerick Lifelong Learning Festival NewsLimerick businessman jailed for money launderingBy Staff Reporter – October 29, 2016 2184 Limerick’s National Camogie League double header to be streamed live Twitter Facebook Print RELATED ARTICLESMORE FROM AUTHOR Limerick Artist ‘Willzee’ releases new Music Video – “A Dream of Peace” WhatsAppcenter_img Linkedin Email TAGSdrug grow houseKenneth Moorelimerickmoney laundering WATCH: “Everyone is fighting so hard to get on” – Pat Ryan on competitive camogie squads Advertisement Previous articleLast minute talks with WRC to avert policing crisisNext articleTop flight soloists, full orchestra and chorus for Aida Staff Reporterhttp://www.limerickpost.ie Limerick Ladies National Football League opener to be streamed live Billy Lee names strong Limerick side to take on Wicklow in crucial Division 3 clashlast_img read more

Read More →

Dublin airport Ryder Cup tweet met with angry responses

first_imgNewsTransportDublin airport Ryder Cup tweet met with angry responsesBy Bernie English – July 26, 2019 1519 Previous articleWATCH: Kiely names unchanged team for All-Ireland semi finalNext articleFreeze on home helps must go Bernie Englishhttp://www.limerickpost.ieBernie English has been working as a journalist in national and local media for more than thirty years. She worked as a staff journalist with the Irish Press and Evening Press before moving to Clare. She has worked as a freelance for all of the national newspaper titles and a staff journalist in Limerick, helping to launch the Limerick edition of The Evening Echo. Bernie was involved in the launch of The Clare People where she was responsible for business and industry news. Twitter WhatsApp Linkedin Mayor of Clare and Shannon councillor Cathal Crowe (FF) says he plans to contact Shannon bosses, Mary Considine and Rose Hynes directly on the matter.“This is predatory and an insult to everyone in the Mid West. Shannon is the gateway airport for the Ryder Cup and Adare, not Dublin.“We down here might be rolling our eyes at this tweet, but that has gone out to the world and that’s what people have seen internationally,” he told the Limerick Post. Facebook Print Advertisement Email A MASSIVE row is brewing following a tweet from the Dublin Airport Authority, which declares it is the gateway airport for the Ryder Cup.The major international golf tournament was this week announced for Adare for 2026 and will bring huge visitor numbers and revenue for the region.Sign up for the weekly Limerick Post newsletter Sign Up But there has been a huge groundswell of anger at the DAA tweet, with people in Limerick and Clare firing angry tweets back.last_img read more

Read More →

PBAF Emergency Relief Fund

first_img Previous articleMusical FundraiserNext articleTEXAS VIEW: Life skills to know as students transition to adulthood admin Pinterest Twitter Facebook WhatsApp Pinterest By admin – May 19, 2018 Facebook Local News Twitter Permian Basin Relief FundWildfires have returned to the Trans Pecos region. While considerable state and federal resources have been deployed to the region, it is unclear when the fires will be fully contained.Individuals wanting to assist with needs associated with the fires and firefighters are encouraged to send donations to the PBAF Emergency Relief Fund.Those wishing to donate may do so by sending donations to: PBAF Emergency Relief Fund, 3312 Andrews Highway, Midland, Texas 79703.Permian Basin Area Foundation is a 501(c)3 tax exempt organization.For more information, call Guy McCrary or Aaron Bedell at 617-3213. WhatsApp PBAF Emergency Relief Fundlast_img read more

Read More →

Evolve Biologics® Completes Phase III Adult and Pediatric Trials for PlasmaCap™ IG (Intravenous Immunoglobulin)

first_img MISSISSAUGA, Ontario–(BUSINESS WIRE)–Feb 9, 2021– Evolve Biologics Inc. (“Evolve”), an innovative plasma-derived therapeutics company, today announced that it has successfully completed its adult and pediatric Phase III clinical trial of PlasmaCap IG (Intravenous Immunoglobulin or “IVIG”), conducted at 12 study centers across the U.S. and Canada. PlasmaCap IG is an investigational IVIG replacement therapy for adult and pediatric patients with primary immune deficiency disease (“PIDD”). The trial assessed the efficacy of PlasmaCap IG by determining whether the mean annual acute serious bacterial infection rate for the therapy was statistically significantly lower than one infection per patient per year. PlasmaCap IG utilizes Evolve’s proprietary PlasmaCap EBA technology, which processes plasma more efficiently and reliably than currently available technologies, enabling Evolve to produce more grams of high-quality immunoglobulin (IG) from each liter of plasma. Upon completion of its first commercial facility, which is already in early development, Evolve plans to submit a Biologics License Application (“BLA”) to the U.S. Food and Drug Administration (“FDA”) and Health Canada, which will include data generated from both the adult and pediatric portions of the trial. “This is a very important milestone for Evolve, bringing us another step closer to our mission to revolutionize the global market for plasma-derived therapeutics. PlasmaCap IG is our first product to complete a Phase III clinical trial and targets a large, critical and underserved global market,” said Jim Caggiano, Chief Executive Officer at Evolve. “The successful completion of both adult and pediatric clinical portions of the trial further validates Evolve’s unique PlasmaCap EBA technology. We are eager to bring PlasmaCap IG to market while we continue to develop new plasma-derived therapeutic options for patients with rare diseases.” Gabriel de Alba, Chairman of Evolve and Managing Director and Partner at The Catalyst Capital Group Inc., added, “Over the past years, with hard work and significant investment, we have built a world-class biologics business. In addition to our experienced leadership team and proprietary PlasmaCap EBA technology, the successful completion of Phase III trials for IVIG indicates Evolve’s tremendous potential to bring new sources of plasma-derived therapeutics business to the global market, for the benefit of patients and medical professionals worldwide.” Key findings from the Phase III trial of PlasmaCap IG include:A total of 839 infusions were administered to 48 adults age 20-70 years (median 51.0 years) and 15 children age 2-16 years (median 9.0 years).There were no acute serious bacterial infections, meeting the primary study endpoint of <1 acute serious bacterial infection per patient-year.The trial also met all of its secondary efficacy and safety endpoints including the following: − Quality of life measures comprising days absent from work or school due to an infection, hospitalization due to infection and febrile days>38.5°C were all low. − More than 98% of the infusions were completed without discontinuation or interruption, and 97% of all treatment-related adverse events reported were mild or moderate; the most common treatment-related adverse events were headache, fatigue and nausea. − No subject experienced a treatment-related serious adverse event, hemolysis, thromboembolism or renal failure. Evolve also announced that the Clinical Immunology Society (CIS) has accepted the abstract “Efficacy and Safety of PlasmaCap IG, A New 10% Intravenous Immunoglobulin Manufactured Using an Innovative Chromatography Process, in Adults and Children with Primary Immunodeficiency Disorders” for poster presentation at the CIS Annual Meeting in April 2021. The poster will provide an overview of the key methods, results, and conclusions from the PlasmaCap IG Phase III trial. “With the completed PlasmaCap IG trial in both adults and children meeting the primary and secondary endpoints, I look forward to the addition of this important new entrant into the immunoglobulin marketplace,” said Richard L. Wasserman, M.D., Ph.D., Medical Director of Pediatric Allergy and Immunology at Medical City Children’s Hospital (Dallas, Texas) and lead investigator of the study. “Primary immunodeficiency patients, who depend on the availability of life-saving immunoglobulin replacement therapy, will be well served by the addition of this high-quality immunoglobulin product, which will increase their treatment options. Augmenting the long-term supply of immunoglobulin is critically important, as seen during the pandemic when there have been challenges to maintaining adequate product to meet patient’s needs.” About PlasmaCap EBA ® PlasmaCap EBA is an innovative technology for efficient capture of plasma proteins at high yields and purities from human blood plasma. The technology uses proprietary affinity adsorbents in expanded bed adsorption (EBA) chromatography to capture plasma proteins directly from plasma or fractionated plasma materials without the use of precipitating solvents such as ethanol. Through substantial development efforts, PlasmaCap EBA ® has been able to demonstrate significant capture yields for major therapeutic plasma proteins. About Evolve Biologics ® Inc. Evolve Biologics Inc. is a leader in the development and commercialization of plasma-derived therapeutics, using its proprietary PlasmaCap EBA purification technology to more efficiently and effectively meet growing global patient demand for these life-saving products. The Company is currently in the process of commercializing an exciting and innovative portfolio of product candidates, including IVIG (intravenous immunoglobulin) and Albumin (human serum albumin), both of which are in advanced stages of regulatory approval in the US (FDA) and Canada (Health Canada). The Company is headquartered in Mississauga, Ontario, Canada. For more information, please visit: www.evolvebiologics.com. Evolve Biologics ® and PlasmaCap EBA ® are registered trademarks of Evolve Biologics Inc. Copyright © 2021 View source version on businesswire.com:https://www.businesswire.com/news/home/20210209005454/en/ CONTACT: MEDIA: Gagnier Communications Jeffrey Mathews / Dan Gagnier +1-646-569-5711 [email protected] KEYWORD: NORTH AMERICA CANADA INDUSTRY KEYWORD: HEALTH GENERAL HEALTH CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Evolve Biologics Inc. Copyright Business Wire 2021. PUB: 02/09/2021 08:00 AM/DISC: 02/09/2021 08:01 AM http://www.businesswire.com/news/home/20210209005454/en Evolve Biologics® Completes Phase III Adult and Pediatric Trials for PlasmaCap™ IG (Intravenous Immunoglobulin) TAGS  Previous articleGreat Northern Hydroponics Projects CA$150,000 in Annual Savings After Fluence LED ImplementationNext articleNextGen Healthcare Powers 1 Million Telehealth Visits in 2020 Digital AIM Web Support Twitter Pinterest Twitter WhatsAppcenter_img Facebook By Digital AIM Web Support – February 9, 2021 Facebook Local NewsBusiness WhatsApp Pinterestlast_img read more

Read More →

Disrupting Pharmacy Benefit Management: RxParadigm Launches to Restore Drug Industry Competitiveness and Reduce the…

first_img Previous articleKingstone Insurance Partners with Flyreel to Offer Breakthrough Contactless Home InspectionsNext articleExperity Tapped by CityMD to Optimize Operations and Truncate Patient Wait Times Digital AIM Web Support TAGS  Twitter Facebook Twitter Pinterest Pinterest CLAYMONT, Del.–(BUSINESS WIRE)–Feb 9, 2021– A seasoned veteran of the prescription drug industry has broken ranks with the status quo and launched a new business to inject more transparency and competitiveness into how drugs are marketed and distributed in the United States. Mesfin Tegenu negotiated billions of dollars of prescription drug contracts with leading pharmaceutical companies over a 25-year career. Now, he intends to use his new company, RxParadigm, to rework the opaque system of how drug rebates are offered and how drug prices are negotiated to reduce costs and increase the availability of life-saving therapeutics to the American public. RxParadigm will focus on increasing competition in a powerful, yet little understood channel, Pharmacy Benefit Management (PBM). Originally conceived in the 1960s, PBMs were created to aggregate the buying power of several insurance companies to drive down drug prices. But as the channel became more concentrated and drug pricing became shrouded in a secretive system of manufacturer rebates, the original intent was lost. The result is seen in ever-escalating prescription drug costs for providers and patients. Net spending on outpatient prescription drugs is expected to rise by more than 5% annually between 2020 and 2028. One way to keep drug costs in check is to encourage healthy competition – something currently lacking in the PBM market due to mega-consolidation that’s depriving the industry of innovation, flexibility, quality, and transparency. The Prescription for Lower Drug Costs RxParadigm seeks to disrupt the industry by leveraging the combined power of regional health plans and the many like-minded PBMs who are slowly losing their customer base to the consolidated market. RxParadigm will then take the unprecedented step of returning all negotiated rebates to regional plans and like-minded PBMs so that these struggling firms can build more innovative and competitive business models, leveling the playing field, and reducing drug costs through market competition. To audit the savings, RxParadigm uses blockchain technology to deliver unparalleled transparency across the entire prescription drug ecosystem. “For all intents and purposes, transparency and competitiveness do not exist in the prescription drug market because of an outdated drug rebate negotiation culture that allows a select few companies to see higher margins and, in turn, dominate the entire prescription drug ecosystem,” said Mesfin Tegenu, the founder and CEO of RxParadigm. “Rebates were supposed to provide discounts based on quality and control, but now they simply guarantee that a few players receive the greatest economic benefit, effectively locking out competition from regional plans and midsize firms.” Building a More Competitive and Agile Marketplace To make these cost savings a reality, RxParadigm offers members a range of tools, allowing, for the first time, regional plans and like-minded PBMs to craft a range of solutions that best meet the needs of providers and patients. “Until now, some PBMs and regional plans did not have the resources to invest in the kind of forward-thinking, patient-centric solutions that improve outcomes and reduce the total cost of health care,” Tegenu said. “Using advanced medication adherence technologies, flexible claims processing, and AI, we offer an array of patient compliance and monitoring tools so payers can see additional cost savings by choosing RxParadigm participating PBMs.” Perhaps the most forward-thinking of these tools allows patients to receive drug discounts directly at point of purchase, allowing providers to meet a Medicare mandate ahead of a 2022 deadline. “We foresee much of these savings to be passed directly to patients in the way of lower out-of-pocket costs for their prescription drug needs,” said Tegenu. A Market Ready, Willing and Able to Compete Response to the RxParadigm model has been nothing short of dramatic. “The entire industry realizes that the basic inequalities inherent in the current system, where a few large players receive the greatest rebates, have stifled competition and fueled drug cost increases,” said Moses Asom, CEO of Trans-Sahara Investment Corporation, which became a charter member of RxParadigm in January of this year. “RxParadigm opens up the current market by providing full transparency into unit cost discounts throughout the channel. With new strategies to increase the buying power of retail pharmacies and make them more competitive, the industry can now provide more services to the client. These initiatives are long past due and are sure to foster a more responsive and less costly health care delivery system.” About RxParadigm RxParadigm delivers transparency and competitiveness to the prescription drug marketplace. Founded by industry veteran Mesfin Tegenu, RxParadigm is reworking the opaque system of how prescription drug rebates are offered and how drug prices are negotiated to reduce the cost and increase availability of life-saving therapeutics to the American public. By neutralizing the PBM market imbalance, RxParadigm provides regional plans and pharmacy benefit management companies with the same economic advantages their larger competitors enjoy, along with the tools they need, including ease of payment for gene therapy, to differentiate themselves and provide more value to the marketplace. www.rxparadigm.com View source version on businesswire.com:https://www.businesswire.com/news/home/20210209005355/en/ CONTACT: Media: Denise DiMeglio [email protected] 610-228-2102 KEYWORD: DELAWARE UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: GENERAL HEALTH OTHER HEALTH HOSPITALS HEALTH PHARMACEUTICAL SOURCE: RxParadigm Copyright Business Wire 2021. PUB: 02/09/2021 09:01 AM/DISC: 02/09/2021 09:02 AM http://www.businesswire.com/news/home/20210209005355/encenter_img WhatsApp Facebook By Digital AIM Web Support – February 9, 2021 WhatsApp Local NewsBusiness Disrupting Pharmacy Benefit Management: RxParadigm Launches to Restore Drug Industry Competitiveness and Reduce the Costs of Prescription Drugs for Americanslast_img read more

Read More →

RoboSense Releases the Latest Version of its Sensor Evaluation System for Autonomous Driving

first_img Previous articleNational Geographic and Double Oscar® Nominee Cynthia Erivo Reveal Highly Anticipated Premiere Date and New Trailer for the Emmy® Award-Winning Anthology Series, GENIUS: ARETHANext articleTesla Store & Service Center in Chicago Metro Area Acquired by Sentinel Net Lease for $10.5MM Digital AIM Web Support Facebook SHENZHEN, China–(BUSINESS WIRE)–Feb 9, 2021– RoboSense LiDAR ( https://robosense.ai/ ) today released the latest version of the ground truth data system and evaluation tool chain RS-Reference 2.1, used for LiDARs and multi-sensor fusion systems performance evaluation. The original RS-Reference version was launched in the market in 2016, when the automotive-grade MEMS solid-state LiDAR RS-LiDAR-M1 project was established. Used by global OEMs and Tier1s, the system has been continuously improved and upgraded with more efficient and useful evaluation function modules and software tool chains. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210209005689/en/ (Photo: Business Wire) While the evaluation function modules can be liked to an exam, the ground truth data is the “answer” for the evaluation of the perception system. Therefore, the accuracy of ground truth data must be significantly higher than the device under test (DuT) in all aspects including detection performance and geometric error. The ground truth data, usually stored in the PB-Level, includes dynamic information such as obstacle types, speeds, and locations, and static information such as lane lines and road boundaries. Data labeling quality and data generation efficiency are the key factors to ground truth data.The RS-Reference system provides a set of ground truth data generation and evaluation solutions, and outputs detection performance and geometric error indicators with a labeling efficiency close to 1:1. This is significantly more accurate than real-time perception, manual labeling and traditional labeling tools.High performance and mature sensor data collection system: the RS-Reference system contains the RoboSense 128-beam LiDAR RS-Ruby, Leopard camera, Continental 408 millimeter-wave radar, GI-6695 RTK, and two added RoboSense RS-Bpearl LiDAR for near-field blind spots in the 2.1 version.Detached roof-mounted deployment without vehicle body modification: the RS-Reference system adapts to different vehicle sizes, does not occupy the sensor installation position of the DuTs, and directly evaluates the intelligent driving system that is consistent with the sensor sets of commercial vehicles.Vastly improved/accumulated perception algorithm and offline processing mechanism: The algorithm is key to smart labeling instead of manual labeling, and is responsible for the extraction of ground truth data. The RS-Reference system uses a customized and dedicated offline perception algorithm, which is the product of RoboSense’s 13+ years’ of accumulated experience of LiDAR sensing algorithm technology. It performs a “full life process tracking and identification” for each obstacle data, and extracts all ground truth data from each frame. The RS-Reference system can pick up speed and acceleration labeling, and accurately delineate the size of the labeling frame through comprehensive shape and size information. The system is also capable of accurately dividing obstacles that are in close proximity to each other in complex scenes.Full-stack evaluation tool chain: it includes data collection tools, sensor calibration tools, visualization tools, manual verification tools, evaluation tools, etc. The 2.1 version upgrades the data management platform and adds the scene semantic labeling function that serves every step of the evaluation process.Individual sensor evaluation in the multi-sensor fusion system: not only can the RS-Reference system evaluate the result of intelligent driving’s perception fusion, but it can also provide targeted solutions based on the features of different types of sensors such as LiDAR, millimeter wave radar, and camera. Dedicated or customized tool modules can be developed according to customer needs for further in-depth analysis of the performance of the sensing system.Extended application value of the RS-Reference: includes planning and control algorithm development support, which is able to generate massive ground truth data to build simulation scenes, and can evaluate road-side perception systems. View source version on businesswire.com:https://www.businesswire.com/news/home/20210209005689/en/ CONTACT: Cassie Gong [email protected] 86-15507590175 KEYWORD: CHINA ASIA PACIFIC INDUSTRY KEYWORD: AUTOMOTIVE MANUFACTURING MANUFACTURING TECHNOLOGY ENGINEERING SOFTWARE SOURCE: RoboSense Copyright Business Wire 2021. PUB: 02/09/2021 02:00 PM/DISC: 02/09/2021 02:00 PM http://www.businesswire.com/news/home/20210209005689/en Facebook RoboSense Releases the Latest Version of its Sensor Evaluation System for Autonomous Driving Twitter WhatsApp Twittercenter_img Pinterest WhatsApp By Digital AIM Web Support – February 9, 2021 TAGS  Pinterest Local NewsBusinesslast_img read more

Read More →